Title : [Doxil--pegylated liposomal doxorubicin].

Pub. Date : 2008 Aug

PMID : 18701868






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Pegylated liposomal doxorubicin (Doxil: PLD) is a liposome-encapsulated form of doxorubicin modified with polyethylene glycol that has been approved for the treatment of AIDS-related Kaposi"s sarcoma. Doxorubicin glycosylphosphatidylinositol specific phospholipase D1 Homo sapiens
2 Pegylated liposomal doxorubicin (Doxil: PLD) is a liposome-encapsulated form of doxorubicin modified with polyethylene glycol that has been approved for the treatment of AIDS-related Kaposi"s sarcoma. Doxorubicin glycosylphosphatidylinositol specific phospholipase D1 Homo sapiens
3 The characteristics of PLD are reduction of the severe side effects of cardiac toxicity and myelosuppression seen with doxorubicin, and a higher anti-tumor effect from the selective high maintenance of the drug concentration in the tumor tissue. Doxorubicin glycosylphosphatidylinositol specific phospholipase D1 Homo sapiens